Frontiers | Progression of Prothrombin Induced by Vitamin K Absence-II in Hepatocellular Carcinoma
Clinical utility of PIVKA-II in the diagnosis of hepatocellular carcinoma | Synnovis
Clinical Utility of Tumor Markers
Epitope characterization of an anti-PIVKA-II antibody and evaluation of a fully automated chemiluminescent immunoassay for PIVKA-II - ScienceDirect
The Relationship between Serum PIVKA-II Levels and the Severity of... | Download Table
Development and evaluation of analytical performance of a fully automated chemiluminescent immunoassay for protein induced by vitamin K absence or antagonist II - ScienceDirect
Assessment of Pivka II as Tumour Marker in Hepatocellular Carcinoma
Pivka-II Monoclonal Antibody (DCP tumor marker) - China Pivka-II, Antibody | Made-in-China.com
Clinical course of the patient. a Tumor markers (AFP, PIVKA-II)... | Download Scientific Diagram
Real impact of tumor marker AFP and PIVKA-II in detecting very small hepatocellular carcinoma (≤ 2 cm, Barcelona stage 0) - assessment with large number of cases
Significance of PIVKA‑II levels for predicting microvascular invasion and tumor cell proliferation in Chinese patients with hepatitis B virus‑associated hepatocellular carcinoma
Efficacy of PIVKA-II in prediction and early detection of hepatocellular carcinoma: a nested case-control study in Chinese patients | Scientific Reports
Clinical value of serum AFP and PIVKA‐II for diagnosis, treatment and prognosis of hepatocellular carcinoma - Tian - Journal of Clinical Laboratory Analysis - Wiley Online Library
PIVKA-II or AFP has better diagnostic properties for hepatocellular carcinoma diagnosis in high-risk patients
Elecsys® PIVKA-II
Real impact of tumor marker AFP and PIVKA-II in detecting very small hepatocellular carcinoma (≤ 2 cm, Barcelona stage 0) - assessment with large number of cases
Clinical utility of PIVKA-II in the diagnosis of hepatocellular carcinoma - Clinical Laboratory int.
Medicina | Free Full-Text | Utility of PIVKA-II and AFP in Differentiating Hepatocellular Carcinoma from Non-Malignant High-Risk Patients
Diagnostic value of the γ-glutamyltransferase and alanine transaminase ratio, alpha-fetoprotein, and protein induced by vitamin K absence or antagonist II in hepatitis B virus-related hepatocellular carcinoma | Scientific Reports
Elecsys® PIVKA-II
PIVKA-II serves as a potential biomarker that complements AFP for the diagnosis of hepatocellular carcinoma | BMC Cancer | Full Text
PIVKA-II is a candidate marker for monitoring the effects of the oral anticoagulant warfarin. | Semantic Scholar
Comparison of AFP and PIVKA-II level in different grades and stages of... | Download Table
Levels of AFP and PIVKA-II in Different Types of Liver Diseases A B | Download Scientific Diagram
Distribution, levels and diagnostic value of PIVKA-II in HCC patients.... | Download Scientific Diagram
PIVKA-II, a biomarker of liver cells for the management of hepatocellular carcinoma (HCC) | Fujirebio
Significance of PIVKA‑II levels for predicting microvascular invasion and tumor cell proliferation in Chinese patients with hepatitis B virus‑associated hepatocellular carcinoma
